ASLAN Pharmaceuticals Initiates Scientific Collaboration to Investigate the Distinct Role of IL-13 Receptor Signaling in Atopic Dermatitis

ASLAN Pharmaceuticals announced that it has initiated a research collaboration with Dr Shawn Kwatra and Dr Madan Kwatra to investigate the unique role of the IL-13Rα1 subunit, distinct from the role of other pathway components, in Type 2-mediated inflammatory diseases, specifically atopic dermatitis.